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ABSTRACT Meta-analysis, the statistical combination of results
from multiple studies, can be used to summarize all of the
available research on an intervention, etiology, descriptive,
or diagnostic test accuracy question. Meta-analysis should be
conducted as a component of a systematic review, to increase
transparency in the selection of studies and to incorporate an
evaluation of the risk of bias in the individual studies included
in the meta-analysis. The process of meta-analysis may include
a forest plot to graphically display the study results and the
calculation of a weighted average summary eﬀect size.
Heterogeneity (diﬀerences in the eﬀect size between studies)
can be evaluated using formal statistics and the reasons for
heterogeneity can be explored using sub-group analysis or
meta-regression. Thus, meta-analysis may be a useful
methodology for preharvest food safety research to aid in policy
or clinical decision-making or to provide input to quantitative
risk assessment or other models.
INTRODUCTION
Meta-analysis refers to the statistical combination
(pooling) of data frommultiple original research studies.
The results from different studies on the same topic
can vary, and meta-analysis provides a means of sum-
marizing a parameter or effect across studies to develop
a more precise estimate of the outcome of interest (1).
The combination of data from multiple studies can be
undertaken using two broad approaches: combining
individual-level data from multiple studies or combining
study-level results (effect sizes) from multiple studies (1).
The former requires the meta-analyst to have access
to all of the original data from each study subject for
each study and is therefore not commonly seen in the
preharvest food safety literature (2), although data-
bases of microbial growth and inactivation kinetics for
foodborne pathogens are available and growing (3).
Therefore, this chapter will focus on meta-analysis in the
context of combining effect sizes from multiple studies
to calculate a summary effect size.
Meta-analyses should be conducted as the statistical
component of a systematic review. The systematic re-
view methodology aims to provide a transparent and
comprehensive summary of the scientiﬁc evidence for
a speciﬁc clinical or policy question. Nesting a meta-
analysis within a systematic review helps to ensure that
all available literature is considered in the summary
effect size estimate. Further, the systematic review meth-
odology explicitly includes an assessment of the risk
of bias in the included studies, thereby reducing the
potential for biased data to inﬂuence the results of the
meta-analysis.
The advantages of meta-analysis include an increased
sample size for estimating a parameter or an effect
size and therefore greater precision in the estimate; the
conﬁdence intervals around a summary estimate can
be calculated and displayed; sensitivity analysis can be
conducted to explore the contribution of speciﬁc studies
to the summary estimate; individual study results may
be weighted by the precision of the effect size estimate
(often partly a function of sample size); and graphical
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methods are available for displaying the results of the
individual studies contributing to the summary estimate
(4). Technically, a meta-analysis can be conducted if at
least two studies with the same outcome are included in
the review, although larger sample sizes increase the
utility of a meta-analysis.
A meta-analysis can address a number of types of
questions. These fall into four general categories: de-
scriptive questions (e.g., prevalence or incidence), inter-
vention questions, exposure questions, and questions
about diagnostic test accuracy (4). All of these question
types are of potential relevance to preharvest food safety.
The results of meta-analyses could be used to inform
clinical or policy decision-making (5) or could be used as
inputs to quantitative risk assessment or other models (3,
6, 7).
Examples of published meta-analyses for intervention
or exposure questions related to preharvest food safety
include evaluations of the effect of direct-fed microbials
on fecal shedding of Escherichia coli O157 in cattle (8),
of vaccination on fecal shedding of E. coliO157 in cattle
(9, 10), and of interventions to reduce Salmonella in
broiler chickens (11–13) and in swine (14) and compar-
isons between the prevalence of enteric pathogens in
organic and traditional production systems (15). These
meta-analyses provide a summary of the totality of
information that is available to address each review
question. Therefore, a policy person, veterinarian, pro-
ducer, or manufacturer can read one meta-analyses to
obtain the scientiﬁc information needed to make a de-
cision on implementing a preharvest intervention rather
than having to read all of the primary literature. Exam-
ples of meta-analyses related to a descriptive question
in preharvest food safety include an evaluation of fac-
tors inﬂuencing the prevalence of Salmonella on swine
farms (16) and a study to estimate the prevalence of
E. coli O157 in cattle (17). The latter meta-analysis also
explored possible explanations for differences in the
prevalence of E. coli O157, such as region, cattle type,
and diagnostic method. For diagnostic test accuracy
questions, meta-analysis has been used to evaluate dif-
ferences in the diagnostic accuracy of culture versus PCR
methods for detection of Salmonella in swine (18).
META-ANALYSIS IN THE CONTEXT
OF SYSTEMATIC REVIEWS
Ideally, meta-analyses are conducted as the statistical
component of a systematic review. Not all systematic
reviews include a meta-analysis due to an insufﬁcient
quantity of data addressing the same question using the
same outcome. However, including a systematic review
approach increases the transparency and rigor of a meta-
analysis.
A number of resources are available that describe
the process of systematic review and meta-analysis in the
context of preharvest food safety (2, 4, 19–23). The steps
of a systematic review include deﬁning the systematic
review question, searching for studies, selecting relevant
studies based on eligibility criteria, extracting data from
relevant studies, assessing the risk of bias in the selected
studies, synthesizing the results qualitatively or quanti-
tatively (meta-analysis), and presenting and interpreting
the results (4).
A systematic review question is built around key ele-
ments, which should be deﬁned in the review question
(4). The deﬁnition of the key elements, and associated
eligibility criteria, set the scope of the systematic review
and, subsequently, the meta-analysis. The broad exam-
ple of Salmonella in swine is used for illustration. For a
descriptive question, the key elements are the population
and the outcome. Thus, a systematic review question
might be “What is the prevalence of Salmonella (out-
come) in market-weight swine (population)?” For an
intervention question, the key elements are the popula-
tion, intervention, comparator, and outcome (PICO).
An example would be “What is the effect of vaccination
(intervention) on fecal shedding of Salmonella (outcome)
compared to no vaccination (comparator) in market-
weight swine (population)?” The key elements of a di-
agnostic accuracy question are the population, index
test, and target organism. An example would be “What
is the sensitivity and speciﬁcity of PCR-based methods
(index test) to identify Salmonella spp. (target organism)
from the feces of market-weight swine (population)?”
The key elements of an exposure question are the pop-
ulation, exposure, comparator, and outcome (PECO).
Exposure questions are common with toxin expo-
sures. An example would be “Is there a dose-response
relationship between high dose exposure to toxin X
(exposure) and liver toxicity (outcome) in humans (pop-
ulation) compared to low dose exposure to toxin X
(comparator)?”
The key elements of the question can then be used to
create eligibility criteria for inclusion of original research
studies in the review. The type of review question also
will determine which study designs are appropriate to
address that question, and study design may be used as
an eligibility criterion. For instance, a systematic review
on the efﬁcacy of a therapeutic intervention may restrict
eligibility of original research studies to only random-
ized controlled trials (RCTs), because this design has the
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highest evidentiary value for questions about interven-
tion efﬁcacy (21).
In preharvest food safety, it is possible to conduct
clinical trials in the species of interest (animal or plant)
with an induced disease outcome (“challenge trials”).
For instance, if researchers wished to evaluate a vaccine
for E. coli O157 in cattle, they could randomly allocate
cattle to receive or not receive the vaccine and then wait
for the animals to be naturally exposed to E. coli O157
(natural exposure trial), or they could deliberately ex-
pose all of the cattle to E. coli O157, perhaps by inoc-
ulating the bacteria into the water or food source
(challenge trial). The advantage of a deliberate disease
exposure is that the researchers can be sure that expo-
sure will take place (in the RCT example, above, it is
possible that the experimental animals would not end up
being exposed to E. coli O157 during the course of the
trial). In a challenge trial, all of the animals in the trial
are exposed to the pathogen of interest, meaning that a
smaller sample size will be needed in a challenge trial
compared to an RCT. However, while challenge trials
often are an efﬁcient way to evaluate proof-of-concept
for an intervention in the species of interest, they are
of lower evidentiary value compared to natural dis-
ease exposure trials (21). The disease challenge may not
represent natural exposure to disease; the challenge may
involve a higher dose of the infectious disease agent or
exposure by a different route than is typical in a natural
exposure. Additionally, with many foodborne agents,
some degree of biocontainment may be needed for
challenge trials, meaning that, for logistical reasons, the
experimental animal population may differ in a mean-
ingful way (i.e., smaller or younger) from the animals for
which the intervention would be used in the ﬁeld.
There is some empirical evidence that the results of
challenge trials differ from the results of natural expo-
sure trials for preharvest food safety interventions (24).
However, for some interventions, data from challenge
trials may be the only form of evidence available; as an
example, 63 of 66 studies included in a meta-analysis of
competitive exclusion products and Salmonella in broiler
chickens were challenge trials (11). Thus, researchers
conducting a meta-analysis will need to consider how, or
whether, to include challenge trials. If there is a sufﬁcient
body of literature using natural exposure trials, then it
might be appropriate to exclude challenge trials, How-
ever, if this is not the case, then the researcher may de-
cide to include both types of trials. If challenge trials are
included in a review, the researcher should evaluate
whether the results differ between natural exposure trials
and challenge trials as a component of the meta-analysis.
The next step of a systematic review is to conduct
a comprehensive and documented search of the peer-
reviewed and “gray” (non-peer-reviewed) literature to
identify all possible publications providing informa-
tion to address the review question. The validity of the
ﬁndings of a systematic review is directly related to the
comprehensiveness of the search and to the reproduc-
ibility of the search protocol (4, 19). Search terms are
created based on the key elements of the question and
the eligibility criteria. These search terms are entered
into electronic databases or used to search other sources.
Although no guidelines have been published on methods
of searching the literature speciﬁcally for preharvest
food safety, guidelines are available for searching the
medical literature (25–27) and the veterinary literature
(28, 29).
The intention is to create a highly sensitive search.
Thus, the speciﬁcity of the search may be low, and it is
necessary to screen the titles and abstracts identiﬁed by
the search to select the original research studies that are
relevant to the review question (30). This is done using a
small number of questions designed to rapidly identify
nonrelevant articles. For instance, if the purpose of the
review is to compare the prevalence of Campylobacter
spp. between organic and traditional swine farms, the
review questions might include the following: (i) Does
the title/abstract describe a primary research study? (ii)
Is Campylobacter in swine a measured outcome? and
(iii) Does the study include both traditional and organic
farms? If the answer to any of these questions is “no,”
then the publication would be excluded from fur-
ther stages of the review. If the answer to any of the
questions is “yes” or “unclear,” then the full publication
would be acquired and the publication would be in-
cluded in subsequent steps of the review. The titles and
abstracts of all citations identiﬁed by the search are in-
dependently assessed by at least two reviewers using the
screening questions, with any disagreements between
reviewers resolved by consensus. Abstracts that are not
relevant are excluded from the review at this stage.
Once relevant studies have been identiﬁed, full articles
are obtained for the relevant studies and data are ex-
tracted. These data include information on study char-
acteristics such as the population (including animal/
plant characteristics and sample sizes in each interven-
tion group), the study setting and details on the inter-
vention, and information on the outcome and results
(23). The data are extracted using structured forms, with
at least two reviewers independently extracting data
from each article. Any disagreements are resolved by
discussion or reference to an additional reviewer.
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The risk of bias also is assessed for each of the relevant
studies included in the review. The important sources of
bias, and the methods used to reduce them, vary between
study designs and review question type. For intervention
questions using RCTs, a common instrument used to
assess bias is the Cochrane risk of bias tool (31), which
focuses on ﬁve domains of bias: selection bias, perfor-
mance bias, detection bias, attrition bias, and reporting
bias. To determine the potential for bias in an original
research study, the reviewer considers sources of bias,
including random sequence generation, allocation con-
cealment, blinding, incomplete outcome data, selective
outcome reporting, and any other potential sources of
bias speciﬁc to the context of the review question. A risk
of bias graph can then be generated to demonstrate the
proportion of studies with each judgment or the indi-
vidual assessments for each study (31). Examples using
hypothetical data are shown in Fig. 1 and Fig. 2.
Risk of bias tools developed for human interven-
tion studies may not address all of the important issues
in preharvest food safety studies (23). However, the
Cochrane risk of bias tool could be modiﬁed for use in
evaluating preharvest food safety trials. For instance,
reviewers maywant to include a consideration of whether
the exposure to a pathogen of interest was due to natural
exposure or whether there was a deliberate pathogen
challenge. If the unit of intervention allocation was at
the group level (for instance, a pen of animals), the re-
viewer may want to include a description of whether
or not the potential for clustering of data was included in
the analysis.
For questions that relate to diagnostic test evalua-
tion, a commonly used risk of bias tool that can be
modiﬁed for food safety is the QUADAS-2 tool (32)
and the Cochrane website devoted to systematic reviews
of diagnostic tests (http://methods.cochrane.org/sdt/).
Authors of reviews about prevalence will likely need
to design a risk of bias tool speciﬁc to the review topic.
This tool should consider the representativeness of the
sample (potential for sampling bias), the reliability of
the test used to assess the outcome and the potential
for information bias, and if applicable, the loss to
follow-up (attrition bias) (33, 34). Risk of bias tools for
nonrandomized studies used for questions about etiol-
ogy are being developed. None are speciﬁc to preharvest
food safety.
The risk of bias assessment should be conducted by
at least two reviewers working independently, with
any disagreements resolved by consensus. Information
on the risk of bias in individual studies can be used
in meta-analysis as a potential explanatory variable in
meta-regression or as a factor in subgroup analysis (see
sections below). Once the data on study characteristics,
study outcomes, and risk of bias are collected, a meta-
analysis can be undertaken.
THE PROCESS OF META-ANALYSIS
Visualizing the Results from Individual Studies
Meta-analysis involves the calculation of a summary
effect size as a weighted average of the results from in-
dividual studies. Describing the terminology surround-
FIGURE 1 Example of a risk of bias graph using hypothetical data (created in Revman
version 5.2). Each study included in the review has been evaluated for the risk of bias based
on the domains shown in this ﬁgure. Each row of the ﬁgure summarizes the proportion of
studies classiﬁed as low risk of bias, high risk of bias, or unclear risk of bias for that domain.
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ing study results can be confusing because studies can
have several layers of outcome. A study subject may
have an outcome (e.g., the organism was detected: yes or
no), those individual results can be compiled to create an
outcome for within an intervention group (e.g., the
proportion positive), and the comparison of the inter-
vention among groups could correspond to the outcome
(e.g., the ratio of the group proportions). For meta-
analysis, the outcome of interest is the comparison level
outcome, i.e., the one number that describes the result of
the comparison.
The actual outcome that is used will vary depending
on the question being addressed by the meta-analysis.
For instance, if the intent is to estimate the prevalence
of a foodborne pathogen, then the outcome will be the
proportion positive (number positive / number at risk).
If the intent of the meta-analysis is to estimate the efﬁ-
cacy of an intervention or to evaluate the impact of
an exposure, the outcome will be a comparison of two
groups, such as a ratio for categorical outcomes (risk
ratio, odds ratio) or the difference in a continuous out-
come (mean difference or standardized mean difference).
For questions about diagnostic tests, the outcome will
be sensitivity and speciﬁcity. The discussion in this sec-
tion will focus on intervention questions, although the
principles apply to any question type.
Data on the outcome are extracted from each of the
individual studies. This may consist of data for each
intervention group (e.g., proportion positive in each
group) or intervention effects at the comparison level
(e.g., relative risk of an event in the treated group versus
the control group). A measure of variability also is ex-
tracted or calculated. For preharvest studies where there
is the potential for nonindependence between interven-
tion groups (e.g., clustering of observations due to animal
grouping), the intervention effect and measure of vari-
ability corrected for nonindependence should be used.
Intervention effects from multiple studies often are
displayed using a forest plot (35) (Fig. 3). Each row in the
forest plot represents an intervention comparison (e.g.,
intervention group versus control group). The x axis
represents the summary outcome of interest. In Fig. 3,
the outcome of interest is a relative risk (risk ratio).
However, the x axis could be another relative measure
such as odds ratio or a parameter such as prevalence,
depending on the speciﬁc question being addressed by
the meta-analysis. For each intervention comparison,
the center of the solid square box corresponds to the
estimated risk ratio obtained for that comparison, and
the size of the box corresponds to the weight given to
that comparison in the meta-analysis. The horizontal
line on either side of the box corresponds to the precision
of the estimate (generally the 95% conﬁdence interval).
When using risk ratios or odds ratios, the effects are
usually plotted on a log-scale to produce symmetrical
conﬁdence intervals. A vertical line drawn at a risk ratio
or odds ratio value of 1.0 represents no difference in the
effect between the intervention groups. For desirable
outcomes, a risk ratio or odds ratio value >1 indicates
that the intervention was effective in improving the
outcome compared to the control group. For example,
if the outcome is being “pathogen negative,” and the
intervention group is 80% pathogen negative and the
control group is 20% pathogen negative, the risk ratio is
4 (0.8/0.2), and the desirable outcome occurs at a 4-fold
FIGURE 2 Example of a risk of bias summary using hypo-
thetical data (created in Revman version 5.2). The results of the
risk of bias assessment for each study for each risk of bias
domain are shown, where “+” (green circles) corresponds to a
low risk of bias in a speciﬁc study for that domain, “-” (red
circles) corresponds to a high risk of bias, and “?” (yellow
circles) corresponds to an unclear risk of bias.
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higher level in the intervention group compared to the
control group. However, in many food safety studies,
the outcome is undesirable (e.g., shedding of a food-
borne pathogen in feces). If that is the case, then relative
risk or odds ratio values <1 indicate a beneﬁcial inter-
vention (i.e., a reduction in shedding). For example, if
the outcome is being “pathogen positive,” and the in-
tervention group is 20% pathogen positive and the
control group is 80% pathogen positive, the risk ratio is
0.25 (0.2/0.8), and the undesirable outcome occurs in
the intervention group at one-quarter of the rate it does
in the control group. The conﬁdence interval describes
our certainty about the magnitude of the effect size. A
conﬁdence interval overlapping the vertical line of “no
effect” represents the lack of a statistically signiﬁcant
association at the 5% alpha level for that comparison.
If the outcome is continuous, such as plant yield,
average daily gain, or log colony forming units of a
pathogen, then the summary effect may be the difference
in means between intervention groups. The vertical line
in a forest plot will then present a 0 difference in means,
the null value. The interpretation of the negative and
positive values is based on how the mean difference is
calculated. For example, if the mean difference is cal-
culated as A – B, then a negative value implies that group
B has a higher mean and a positive value means that
group A has a higher mean.
While a graphic display of the results from individual
studies provides a useful visual representation of inter-
vention effectiveness, it is inappropriate to generate in-
ferences based on a graphical display. It is necessary to
conduct a formal meta-analysis to statistically combine
the results from the individual studies to make inferences
regarding the statistical signiﬁcance of the summary
effect size.
Calculating a Summary Eﬀect
Meta-analysis involves the calculation of a weighted
mean of the results from the individual studies; thus,
each observation in the meta-analysis is the result from
an original research study. A simple arithmetic mean
of the results across all trials would give misleading
results, because small studies are more subject to ran-
dom error and therefore should be given less weight
(36). The larger the weight given to a speciﬁc study,
the more the results of that study will contribute to the
weighted average summary effect measure. The weights
are therefore chosen to reﬂect the amount of information
that each study contains.
Meta-analysis is based on one of two basic statistical
models, either a ﬁxed effect or a random effects model (1,
31). The underlying assumption of a ﬁxed effect model
is that there exists a “true effect size” (intervention efﬁ-
cacy), and therefore any difference between studies is the
result of sampling error (chance). In contrast, the ran-
dom effects approach assumes that there may be differ-
ent effect sizes underlying different studies (for example,
the effect size may vary based on characteristics of
the study populations) (1). Random effects models gen-
erally produce a point estimate of the summary effect
size that is similar to that obtained from a ﬁxed-effects
model, but with wider conﬁdence intervals. Random
effects models are generally more appropriate and pro-
vide a more conservative estimate. In the absence of
heterogeneity (differences among studies), a ﬁxed effect
model will produce the same results as a random effects
model.
In a ﬁxed effect meta-analysis, it is assumed that the
observed intervention effect varies between studies only
because of the random error inherent in each study.
Therefore, the weight assigned to each study is com-
monly based on the inverse of the study’s variance (1).
With this approach, larger studies (which have smaller
FIGURE 3 Forest plot illustrating relative risk of retreatment
for bovine respiratory disease following treatment with tul-
athromycin compared to other available antibiotic treatments
(61). Each row corresponds to treatment comparison, with the
box representing the relative risk estimate for the comparison
and the line corresponding to the 95% conﬁdence interval
around that estimate. The size of the box is representative
of the relative amount of information contributed for that
comparison (study weighting). The vertical line represents the
null eﬀect (relative risk of 1).
6 ASMscience.org/MicrobiolSpectrum
Sargeant and O’Connor
Downloaded from www.asmscience.org by
IP:  129.186.176.122
On: Wed, 13 Dec 2017 19:30:24
standard errors/variance) are given more weight than
smaller studies (which have larger standard errors). There
are three common approaches to estimating the weights:
the inverse variancemethod, theMantel-Haenszel method,
and the Peto’s odds ratio method (31, 37).
In the inverse variance method, the weight assigned
to each study is the reciprocal of the squared standard
error. The inverse variance method has wide applica-
bility, because this approach can be used for either di-
chotomous or continuous data and requires that each
study provide only an intervention effect estimate and a
standard error. In some instances, an intervention effect
such as the odds ratio (for categorical data) can be cal-
culated from the data provided in a publication. Again,
for categorical data, when zero cells (no events in one
arm of a study) are present in a study, it is necessary to
add a small quantity (generally 0.5) to that cell to allow
calculation of the odds ratio (37, 38). When data are
sparse, either because of low event rates or small trials,
estimates of the standard error are poor. In these in-
stances, the Mantel-Haenszel or Peto method may be
preferred.
In a random effects meta-analysis, it is necessary to
compute both the within study variance and the between
study variance (the variance of the intervention effect
size across the population of studies). A commonmethod
is the DerSimonian and Laird model (39), in which the
study effects are assumed to follow a normal distribu-
tion, with the variance of that distribution estimated
from the data.
The random effects method tends to be more conserv-
ative (wider conﬁdence intervals on the summary effect
size) compared to the ﬁxed effect method and gives rel-
atively more weight to smaller studies. The DerSimonian
and Laird random effects method has the same wide
applicability as ﬁxed effect models, in that it can be used
for studies with any type of outcome data as long as an
intervention effect and standard error are provided in
the individual studies or can be calculated from the data
presented (37).
Evaluating Heterogeneity
While meta-analysis produces an estimate of the sum-
mary effect size, it is equally important to understand
the consistency of that effect size across studies. For in-
stance, the applicability of an intervention that consis-
tently reduced fecal shedding of a foodborne pathogen
by 50% across all studies would differ from an inter-
vention that resulted in an average reduction in fecal
shedding of 50% but ranged from 10% to 90% in the
individual studies that contributed to that average.
Heterogeneity refers to the differences in effect sizes
among studies (31). Variations in effect size between
studies may be due to random error (chance) or “true”
heterogeneity. True heterogeneity may occur due to
differences between studies in characteristics of the
populations, due to interventions and outcomes (“clini-
cal heterogeneity”), and/or due to differences between
studies in study design or risk of bias (“methodological
heterogeneity”) (40). For instance, if an intervention had
a different effect in preweaned animals compared to
adult animals, and studies with different ages of animals
were included in the meta-analysis, then “age”would be
a source of clinical heterogeneity in the results. Alter-
natively, if an antibiotic had a different efﬁcacy when
administered intravenously compared to intramuscu-
larly, and if studies evaluating both methods of admin-
istration were included in the meta-analysis, then “route
of administration” would be a source of clinical het-
erogeneity. If studies that employed blinding of the
outcome assessor tended to have a different effect size
compared to studies that did not use blinding, and if
both types of studies were included in the meta-analysis,
then “blinding of outcome assessor” would be a source
of methodological heterogeneity. If substantive hetero-
geneity exists, it may not be meaningful or appropriate
to calculate a summary effect size.
Heterogeneity should be evaluated as a component
of all meta-analyses; the evaluation may be used to pro-
vide context on the degree of difference among studies
in the review, to determine whether pooling of results
should be undertaken, or as a ﬁrst step for evaluating
possible sources of heterogeneity. A variety of formal
statistical tests are available to evaluate heterogeneity
among a group of studies (41). One commonly used test
to determine whether or not heterogeneity is present
(at a predetermined P value cut-point) is Cochran’s
chi-square test of homogeneity (sometimes known as
Cochran’s Q or simply Q). This test measures deviation
of observed effect sizes from an underlying overall effect
size. The null hypothesis for the Q test is that there is
homogeneity of effect sizes among the studies included
in the analysis; therefore, rejection of the null hypothesis
implies that heterogeneity is present. However, the Q
test may be a poor indicator of true heterogeneity among
studies if a small number of studies are included in
the calculation, resulting in low power to detect het-
erogeneity. It is common that a P value cut-off of 0.10 or
larger be used as a signiﬁcance level, although this ap-
proach carries the risk that when many large studies are
available, a clinically unimportant difference could be
signiﬁcantly heterogeneous.
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In addition to testing for the presence or absence of
heterogeneity, it is possible to quantify the amount of
heterogeneity. The I2 test provides an estimate of the
proportion of total variability that can be attributed to
heterogeneity beyond chance. I2 lies between 0% and
100%, with a value of 0% indicating no observed het-
erogeneity and larger values corresponding to increasing
heterogeneity beyond that expected by chance. The I2 is
less affected by the number of studies in the analysis
compared to the Q test (41), although this has been
disputed (42). Given that the Q test and I2 statistic both
contribute to understanding heterogeneity in a meta-
analysis, both should be calculated and reported.
One of the most difﬁcult questions in meta-analysis is
How much heterogeneity is too much for calculating a
summary effect size? Heterogeneity will always exist,
and the question is actually What is meaningful het-
erogeneity (43)? As a general guideline, I2 values of 0
to 40% are likely unimportant, 30 to 60% represents
moderate heterogeneity, 50 to 90% represents substan-
tial heterogeneity, and 75 to 100% represents consid-
erable heterogeneity (31). As an example of the range
of heterogeneity estimates that have been reported in
the food safety literature, Totton et al. (13) conducted
21 random-effects meta-analyses on different feed and
water additives to evaluate their effect on Salmonella
concentration or prevalence in the ceca of broiler
chickens. The I2 estimates for the meta-analyses ranged
from 0 to over 95%; the authors did not report summary
estimates for meta-analyses where heterogeneity was
statistically signiﬁcant.
Exploring Causes of Heterogeneity:
Meta-Regression and Subgroup Analysis
Testing and reporting the magnitude of heterogeneity
does not help to explain the factors associated with
heterogeneity. Subgroup analysis and meta-regression
are tools in meta-analysis that are used to understand
factors associated with heterogeneity.
Subgroup analysis involves splitting the original
studies into subgroups to make comparisons between
them (for example, based on geographic location or
other population characteristics or based on indicators
of study quality such as randomized versus nonrandom-
ized trials). Subgroup analysis may be conducted to
explore heterogeneity or to address speciﬁc questions
about populations or types of studies (31). For instance,
researchers might be interested in evaluating the efﬁcacy
of vaccination for a foodborne pathogen separately for
dairy cattle and for beef cattle, or in calves versus adult
cattle. Snedeker et al. (9) used subgroup analysis to
evaluate two vaccine types for reducing fecal shedding of
E. coli O157 and found that reduction in fecal shedding
was similar between the two vaccine types. Subgroup
analysis is limited to comparisons of a single variable
that is categorical. However, numerous subgroup anal-
yses can be conducted. Subgroup analysis can be a useful
tool for exploring data but should be used with caution,
particularly if the subgroups were not identiﬁed a priori,
due to the increased probability of false-positive signif-
icance tests as multiple tests are performed.
If it is of interest to explore multiple potential ex-
planatory variables or a continuous covariate as a source
of heterogeneity, then meta-regression can be used.
Meta-regression is a weighted regression where the unit
of concern is the study, and the outcome of interest is the
effect of the intervention at the study level. The weights
in meta-regression are frequently the inverse variance of
each study’s result. The regression coefﬁcient describes
how the outcome variable changes with a unit increase
in the explanatory variable. If the summary effect is a
ratio measure, such as a risk ratio or odds ratio, the log-
transformed value of the intervention effect is used, and
the exponent of the regression coefﬁcient gives an esti-
mate of the relative change in intervention effect size
with a unit increase in the explanatory variable. Meta-
regression allows the exploration of potential sources
of heterogeneity or potential biases (such as indicators
of study quality). Examples of meta-regression in the
food safety literature include an evaluation of study-
level predictors on the prevalence of Salmonella on
swine farms (16) and an investigation of both study-level
variables and methodological criteria as explanatory
variables in a meta-regression on the effect of com-
petitive exclusion products on Salmonella in broiler
chickens (11). Wisener et al. (24) used meta-regression
and subgroup analyses to evaluate whether interven-
tion effect sizes differed between challenge trials and
natural exposure trials for three food safety pathogen–
commodity group combinations.
An excellent review of the advantages and disadvan-
tages of meta-regression is available (41). If the number
of studies is limited, factors might be investigated one
at a time in univariate regressions, or if there are sufﬁ-
cient data, a multivariable regression model could be
built. However, investigation of multiple factors is often
not possible due to inadequate numbers of studies.Meta-
regression should generally not be considered when there
are few studies; a rough guideline is that more than
10 studies should be available before considering meta-
regression as an approach to exploring heterogeneity
(31).
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Limitations of Meta-Analysis
A meta-analysis can only assess the literature that is
available to the investigators. A large amount of the
actual research conducted for many interventions may
not be available in the public domain, and this may
serve as a source of bias in the estimation of the sum-
mary effect measure if availability is associated with
the effect size. This type of bias is called reporting bias
and has several subcategories: publication bias, time lag
bias, duplicate publication bias, location bias, citation
bias, language bias, and outcome reporting bias (31, 39,
44).
Publication bias refers to the tendency for studies
that do not show a signiﬁcant effect not to be published,
particularly if the sample size was small (either because
they are not submitted for publication or because jour-
nals are more reluctant to publish them) (45).
Time lag bias is related to the tendency for trials
showing a positive intervention effect to be published
faster than trials that report nonstatistically signiﬁcant
results. Thus, recent nonsigniﬁcant trials may not be
available in the public domain as quickly as trials show-
ing a signiﬁcant difference. Trials showing a signiﬁcant
difference may be more likely to be available in multiple
forums (e.g., conference proceeding, report, and peer-
reviewed publication), thereby resulting in duplicate
publication bias. Trials showing a signiﬁcant interven-
tion effect also tend to be published in higher-proﬁle
journals, which are more likely to be indexed in elec-
tronic databases and are more likely to be cited. This
results in easier identiﬁcation for inclusion in a meta-
analysis using standard literature search methods, re-
sulting in location bias and citation bias. Literature
published in the English language also is easier to iden-
tify in searches, and if non-English articles are identiﬁed,
there may not be the resources to translate the articles
for inclusion in the meta-analysis. There is some evi-
dence in the human health care literature that published
non-English trials tend to be smaller, of lower quality,
and more likely to report a statistically signiﬁcant dif-
ference, although the effect on the overall intervention
estimate may not be large (46). Finally, there is evidence
that, even within published trials, statistically signiﬁcant
outcomes are more likely to be reported than nonsig-
niﬁcant outcomes, leading to outcome reporting bias
(47). A study of conference proceeding abstracts report-
ing on food safety intervention studies at the preharvest
and abattoir level reported that less than half of the re-
search reported in conference abstracts was published
in the peer-reviewed literature within 4 years (48). The
same study found that conference abstracts reporting at
least one positive outcome were more likely to be sub-
sequently published and were published faster than
those reporting nonsigniﬁcant ﬁndings.
One approach to evaluating publication bias in a
meta-analysis is to create a funnel plot, which can be
visually examined for signs of asymmetry (47, 49).
Funnel plots are simple scatter plots of the intervention
effect sizes estimated from individual studies (on the
x axis) against some measure of each study’s precision
(y axis), usually the standard error. The name “funnel”
is used because precision in the estimation of the true
intervention effect size should increase as the sample size
of the studies included in the meta-analysis increases.
Therefore, the expectation would be that effect sizes
from small studies would scatter more widely at the
bottom of the graph, with smaller differences in the es-
timated effect size among larger studies. Theoretically, in
the absence of bias, the plot should resemble a sym-
metrical inverted funnel. Therefore an assessment of the
symmetry of a funnel plot is actually an assessment of
small study effects. Although funnel plots are often said
to assess publication bias, they actually assess whether
small studies have different effect sizes compared to
larger studies. Publication bias may be one cause of
small study effects. Other possible sources of asymmetry
in funnel plots can include (i) selection bias, location
bias, language bias, citation bias, or multiple publica-
tion bias; (ii) poor methodological quality of smaller
studies; (iii) true heterogeneity where the magnitude
of the intervention effect size differs according to study
size (for example, due to differences in the intensity of
interventions); (iv) artifactual (sampling variation can
lead to an association between the intervention and its
standard error); or (v) chance. There are a number of
statistical tests to formally evaluate asymmetry in a
funnel plot rather than relying on a visual assessment for
details (see 45, 50, 51).
Reporting the Results of a Meta-Analysis
As with any type of study, it is important that meta-
analyses (and systematic reviews) are reported in suf-
ﬁcient detail to enable the reader to determine how
the meta-analysis was conducted and to evaluate the
potential for biased results. The PRISMA statement
(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses; www.prisma-statement.org) provides
guidelines for reporting the results of systematic re-
views, including the meta-analysis component (52). An
accompanying elaboration document provides explana-
tions for each of the recommended items and examples
of good reporting (53).
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CHALLENGES
The main challenges associated with meta-analysis are
publication bias (as discussed in the previous section),
insufﬁcient quantity of research available to address the
question of interest, lack of comprehensive reporting
of the effect sizes, and high risk of bias in the primary
studies. Theoretically, a meta-analysis can be done if two
relevant studies are available. However, meta-analysis
becomes more informative when there are more studies
for inclusion. When the number of studies does not war-
rant a meta-analysis, a narrative summary may still be
useful and can provide insights and directions for further
research.
The challenge with poor-quality studies in meta-
analysis is the “garbage in, garbage out” paradigm.
There is evidence in the human health care literature
that trials that do not report important methodological
features aimed at reducing bias have exaggerated inter-
vention effects (54–57), and there is some evidence that
the same is true in preharvest food safety trials (58).
Guidelines are available to describe the items that should
be reported in preharvest food safety clinical trials (59,
60; www.reﬂect-statement.org). While it is possible that
a well-reported trial was conducted poorly, it is essential
that the reader of a trial know what was done in the trial
in order to make an informed decision about the likeli-
hood of bias. A major advantage of conducting meta-
analysis as a component of a systematic review is that
risk of bias assessment will have been conducted on each
of the studies. This information can be included in a
meta-analysis and in the interpretation of the results of
the meta-analysis.
SUMMARY
Meta-analysis is the statistical pooling of data from mul-
tiple studies. Including meta-analysis as the analytical
component of a systematic review increases the trans-
parency and rigor of the analysis. The steps to a meta-
analysis include extracting the data from the original re-
search studies and displaying the data using a forest plot,
combining the data using either a ﬁxed effect or a ran-
dom effects models, and evaluating heterogeneity. If the
amount of heterogeneity suggests that a single summary
effect size does not well represent the data, it may not be
appropriate to report a summary effect size. Reasons for
heterogeneity can be explored using meta-regression or
subgroup meta-analysis. Meta-analysis may be a useful
methodology for preharvest food safety research to aid in
policy or clinical decision-making or to provide inputs to
quantitative risk assessment or other models.
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